ArticleMolecular psychiatry2026
Shared cortical morphometry and molecular signatures across depression and physical diseases.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Major depressive disorder (MDD) is highly comorbid with physical diseases, suggesting shared neurobiological mechanisms. However, the common structural and molecular substrates underlying this comorbidity remain poorly understood. We analyzed multimodal MRI data from 577 patients (MDD, asthma, fibromyalgia, gastroesophageal reflux disease, type 2 diabetes) and 275 healthy controls, constructed individual morphometric similarity networks (MSN) to identify shared cortical alterations, and applied principal component analysis with multiscale molecular annotation (transcriptomic, cell-type, neurotransmitter, and cognitive mapping) to characterize underlying mechanisms. All patient groups exhibited regional MSN abnormalities. A shared MSN pattern emerged, featuring increased similarity in visual and somatomotor regions and decreased similarity in ventral attention, limbic, and default mode networks, and was replicated in independent cohorts. This pattern was significantly associated with spatial gene expression enriched for synaptic signaling, membrane potential regulation, and neuronal architecture, with predominant expression in excitatory/inhibitory neurons and astrocytes. It further mapped onto specific neurotransmitter systems, with exploratory cognitive decoding suggesting possible relevance to emotion and social cognition. Related genes overlapped with known risk loci for Alzheimer's disease and bipolar disorder. These findings identify a robust across diseases cortical MSN phenotype linked to convergent molecular and neurochemical correlates, offering a framework for studying shared vulnerability and transdiagnostic mechanisms across depression and physical diseases.
Identifiers
42897264What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.